ArticleJournal of clinical and experimental hematopathology : JCEH2024

Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases.

Masuho Saburi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.